Watch

ZYMEZymeworks Inc.

Healthcare · Biotechnology · small-cap ($1.7B)
-20.1%
from rolling 252-day high of $31.34 set 2026-09-03 · 43d ago
Current
$25.03
Decline depth
-20.1%
Decline σ
4.5σ
TFC
1/5 bearish

Where it stands

On the Watch.

Down 20.1% from its rolling 252-day high, 43 days after the high.

Snapshot . Price structure, not a judgment about the business.

What changed

Since the previous observation.

Tier and recovery signal are unchanged between these two observations.

Comparing with . This compares classification, not price returns.

See the recorded timeline →

Why it is flagged

ZYME qualifies for the Watch on decline depth.

Down 20.1% from its rolling 252-day high, 43 days after the high. The most severe triggered rule determines the tier.

Inspect the three classification measures
Decline depth
-20.1%
From rolling 252-day high of $31.34, 43d ago. Past the 20% Watch threshold.
Time-frame continuity
1/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
4.5σ
Drop over the last 20 bars in units of daily volatility (2.63%/day). Past the ≥4σ Watch threshold.

Price history

The price path behind the snapshot.

Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.

Rolling 252-day high Gold dots: recorded classification events (see timeline) Up day Down day 90 daily bars from Alpaca · through

The recorded history

A timeline of observations.

First observed 2026-05-15. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.

  1. Amber List → Watch
  2. Watch → Amber List
  3. Unmatched; coverage or recovery unconfirmed → Watch
  4. Watch → Unmatched; coverage or recovery unconfirmed
  5. Unmatched; coverage or recovery unconfirmed → Watch
  6. Watch → Unmatched; coverage or recovery unconfirmed
  7. Unmatched; coverage or recovery unconfirmed → Watch
  8. Watch → Unmatched; coverage or recovery unconfirmed
  9. Amber List → Watch
  10. Red List → Amber List
  11. Watch → Red List
  12. Unmatched; coverage or recovery unconfirmed → Watch

Showing the latest 12 of 27 recorded events.

Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.

Technical interpretation and signal details

The structural read

What price action says about ZYME.

ZYME qualifies for the Watch on decline depth — down -20.1% from its rolling 252-day high.

Cross-confirmation: decline sigma also reads 4.5σ over 20 bars.

Earnings on file: 2026-08-06. Earnings dates don't affect tiering.

Questions about ZYME

What people ask.

Why is ZYME on Broken Stocks?

ZYME qualifies for the Watch on decline depth. It is down -20.1% from its rolling 252-day high of $31.34, set on 2026-09-03 — 43d ago.

Is ZYME a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. ZYME is down -20.1% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is ZYME a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is ZYME trading inside its 52-week range?

At $25.03, ZYME sits 74.1% of the way from its 52-week low ($11.51) to its 52-week high ($29.75). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has ZYME been declining?

The current 20.1% decline accrued over 43d, which annualizes to roughly -170.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does ZYME compare to its sector?

There are 408 other Healthcare tickers on Broken Stocks: 274 Red, 95 Amber, 39 Watch, with 178 showing recovering structural signals. Median sector decline is -37.5% — ZYME's decline is shallower than the sector median.

Does ZYME's earnings date affect its tier?

No. Tiering uses decline depth and recency, bearish time-frame structure, and decline sigma. The earnings date on file (2026-08-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.